Duodopa

Duodopa (EU,Japan), Duopa (US), (ABT-SLV187) is a first line therapy for advanced Parkinson's disease patients with severe motor fluctuations, when conventional oral therapy is not effective.

Type of Molecule

Small Molecule

Target

Dopamine

Product Type

New Indication
Potential Indication Region Phase (1, 2, 3, Submitted, Approved)
Parkinson's Disease US, EU, JPN
Approved